| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 207.31B | 208.72B | 180.34B | 152.55B | 142.13B | 175.19B |
| Gross Profit | 164.79B | 172.31B | 143.40B | 129.13B | 114.63B | 160.39B |
| EBITDA | 49.39B | 57.13B | 41.63B | 31.79B | 297.00M | 42.96B |
| Net Income | 33.51B | 35.35B | 25.22B | 17.89B | -13.01B | 24.96B |
Balance Sheet | ||||||
| Total Assets | 12.99T | 12.99T | 12.55T | 12.21T | 12.18T | 11.99T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.86T | 1.39T | 1.88T | 2.18T | 1.81T |
| Total Debt | 1.16T | 1.39T | 1.29T | 1.58T | 1.04T | 1.94T |
| Total Liabilities | 12.35T | 12.37T | 11.89T | 11.60T | 11.55T | 11.31T |
| Stockholders Equity | 632.53B | 619.04B | 652.79B | 611.85B | 629.96B | 674.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 5.25B | -147.81B | -80.64B | 1.12T |
| Operating Cash Flow | 0.00 | 0.00 | 13.52B | -143.35B | -77.13B | 1.12T |
| Investing Cash Flow | -146.62B | -146.62B | -493.73B | -155.57B | 461.97B | -292.74B |
| Financing Cash Flow | 3.60B | 3.60B | -94.00M | 1.76B | -13.20B | 8.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥534.83B | 9.62 | ― | 3.15% | 14.15% | 77.69% | |
70 Outperform | ¥516.14B | 15.28 | 6.09% | 2.93% | 9.29% | 38.31% | |
70 Outperform | ¥560.46B | 9.42 | ― | 3.21% | 21.89% | 20.28% | |
69 Neutral | ¥714.50B | 9.74 | ― | 1.41% | 28.56% | 62.62% | |
67 Neutral | ¥522.23B | 15.13 | ― | 2.93% | 11.61% | 46.17% | |
66 Neutral | ¥555.22B | 10.79 | 5.53% | 2.02% | 15.94% | 64.09% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |